Methods and compositions for treating autoimmune disease

Details for Australian Patent Application No. 2008279618 (hide)

Owner Alexion Pharmaceutical, Inc.

Inventors Wang, Yi

Agent Shelston IP

Pub. Number AU-A-2008279618

PCT Pub. Number WO2009/014744

Priority 60/962,044 25.07.07 US

Filing date 25 July 2008

Wipo publication date 29 January 2009

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

18 February 2010 PCT application entered the National Phase

  PCT publication WO2009/014744 Priority application(s): WO2009/014744

20 May 2010 Alteration of Name

  The name of the applicant has been altered to Alexion Pharmaceuticals, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008279619-Antibodies to CD200 and uses thereof in inhibiting immune responses

2008279616-A device and method to clamp and lock permanent magnets and improve cooling within a rotating electrical machine using pitched focused flux magnets